These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37098094)

  • 1. Disparate properties of Burkholderia multivorans and Pseudomonas aeruginosa regarding outer membrane chemical permeabilization to the hydrophobic substances novobiocin and triclosan.
    Ruskoski SA; McDonald AA; Bleichner JJ; Aga SS; Boyina K; Champlin FR
    PLoS One; 2023; 18(4):e0284855. PubMed ID: 37098094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate outer membrane exclusionary properties underlie intrinsic resistance to hydrophobic substances in
    Chambers LE; Chang M; Boyina K; Williams A; Dye R; Miller RV; DeGear MA; Assefa S; Köhler GA; Champlin FR
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(3):257-268. PubMed ID: 33411598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of outer membrane permeabilization on intrinsic resistance to the hydrophobic biocide triclosan in opportunistic
    Kavya B; King B; Rigsbee AS; Yang JG; Sprinkles W; Patel VM; McDonald AA; Amburn SK; Champlin FR
    Heliyon; 2023 Apr; 9(4):e15385. PubMed ID: 37101640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa.
    Champlin FR; Ellison ML; Bullard JW; Conrad RS
    Int J Antimicrob Agents; 2005 Aug; 26(2):159-164. PubMed ID: 16040235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan.
    Ellison ML; Roberts AL; Champlin FR
    FEMS Microbiol Lett; 2007 Apr; 269(2):295-300. PubMed ID: 17263842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida.
    Morris CM; George A; Wilson WW; Champlin FR
    J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of methylation on the antibacterial properties of triclosan in Pasteurella multocida and Pseudomonas aeruginosa variant strains.
    Clayborn AB; Toofan SN; Champlin FR
    J Hosp Infect; 2011 Feb; 77(2):129-33. PubMed ID: 21194793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan.
    Ellison ML; Champlin FR
    Vet Microbiol; 2007 Oct; 124(3-4):310-8. PubMed ID: 17560745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia.
    Loutet SA; El-Halfawy OM; Jassem AN; López JM; Medarde AF; Speert DP; Davies JE; Valvano MA
    Int J Antimicrob Agents; 2015 Oct; 46(4):376-80. PubMed ID: 26187366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of hopanoid biosynthesis genes involved in polymyxin resistance in Burkholderia multivorans.
    Malott RJ; Steen-Kinnaird BR; Lee TD; Speert DP
    Antimicrob Agents Chemother; 2012 Jan; 56(1):464-71. PubMed ID: 22006009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia.
    Bertot GM; Restelli MA; Galanternik L; Aranibar Urey RC; Valvano MA; Grinstein S
    Infect Immun; 2007 Jun; 75(6):2740-52. PubMed ID: 17296759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface physiology and outer cell envelope impermeability for hydrophobic substances in Burkholderia multivorans.
    Ruskoski SA; Champlin FR
    J Med Microbiol; 2017 Jul; 66(7):965-971. PubMed ID: 28721855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial synergism of polymyxin B nonapeptide and hydrophobic antibiotics in experimental gram-negative infections in mice.
    Ofek I; Cohen S; Rahmani R; Kabha K; Tamarkin D; Herzig Y; Rubinstein E
    Antimicrob Agents Chemother; 1994 Feb; 38(2):374-7. PubMed ID: 8192470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism.
    Gilleland HE; Farley LB
    Can J Microbiol; 1982 Jul; 28(7):830-40. PubMed ID: 6293694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer Membrane Interaction Kinetics of New Polymyxin B Analogs in Gram-Negative Bacilli.
    Akhoundsadegh N; Belanger CR; Hancock REW
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function studies of polymyxin B nonapeptide: implications to sensitization of gram-negative bacteria.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    J Med Chem; 2000 Aug; 43(16):3085-92. PubMed ID: 10956216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The outer membrane permeability-increasing action of linear analogues of polymyxin B nonapeptide.
    Vaara M
    Drugs Exp Clin Res; 1991; 17(9):437-43. PubMed ID: 1822436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New antimicrobial peptide-antibiotic combination strategy for Pseudomonas aeruginosa inactivation.
    Han W; Wei Z; Camesano TA
    Biointerphases; 2022 Aug; 17(4):041002. PubMed ID: 35922283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.